| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 01/10/2002 | WO2002002152A1 Photodynamic treatment and uv-b irradiation of a thrombocyte suspension |
| 01/10/2002 | WO2001039764A3 Methods for treating conditions and illnesses associated with abnormal vasculature |
| 01/10/2002 | US20020004053 Identifying a cellular/acellular organism site on living body and combining administration of adjuvant which increases immune response (builds antibodies) and photodynamic light causing necrosis |
| 01/10/2002 | US20020004044 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 01/09/2002 | EP1170019A2 Homeopathic device for rendering of homeopathic information |
| 01/09/2002 | EP1169082A1 Method of providing cosmetic/medical therapy |
| 01/09/2002 | EP0683671B1 Immune system modulation using psoralens activated with visible light |
| 01/09/2002 | CN1330549A Method for preventing and reversing atherosclerosis in mammals |
| 01/08/2002 | CA2163636C Process for the sterilization of biological compositions and the product produced thereby |
| 01/03/2002 | WO2002000906A2 Replication deficient adenoviral tnf vector |
| 01/03/2002 | WO2002000870A2 Method for transfecting cells using a magnetic field |
| 01/03/2002 | WO2001035996A3 Use of pdt to inhibit intimal hyperplasia |
| 01/03/2002 | WO2001024825A3 Significance of dosimetry in photodynamic therapy of injured arteries |
| 01/03/2002 | US20020002162 Synergistic methods and compositions for treating cancer |
| 01/03/2002 | US20020001567 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 01/03/2002 | US20020001565 Radioprotective agents |
| 01/03/2002 | CA2412637A1 Replication deficient adenoviral tnf vector |
| 01/02/2002 | EP1166784A1 Inhibitors for vascular reconstriction after angioplasty |
| 01/02/2002 | EP1166291A1 Heating of magnetic material by hysteresis effects |
| 01/02/2002 | EP0983273B1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 01/02/2002 | EP0877785B1 Novel plant extracts, preparation method therefor and use thereof in cosmetics |
| 12/27/2001 | WO2001098294A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | WO2001097848A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097814A1 Photosensitizers with ligand targeting properties for tumor therapy |
| 12/27/2001 | WO2001097806A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 12/27/2001 | WO2001097750A2 Method for producing an antiviral agent |
| 12/27/2001 | WO2001035952A8 Radiosensitization of human glioblastoma cells by quinazoline compounds |
| 12/27/2001 | WO2001026684A3 Method for treating hypoxic cells |
| 12/27/2001 | US20010056255 Effect of electric field and ultrasound for transdermal drug delivery |
| 12/27/2001 | US20010056065 Drug delivery complex molecule with "parachute" structure which hinders structure from going through the cell membrane and a drug that can penetrate the membrane; for photodynamic therapy and chemotherapy |
| 12/27/2001 | US20010055589 Cancer immunotherapy improved by prior radiotherapy |
| 12/27/2001 | CA2413957A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2412362A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 12/25/2001 | US6333319 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 12/25/2001 | CA2176258C Device and method for photoactivation |
| 12/20/2001 | WO2001096343A1 Substituted metal-phthalocyanines, their preparation and the use thereof |
| 12/20/2001 | WO2001095944A2 Photocleavable prodrugs for selective drug delivery |
| 12/20/2001 | WO2001095937A2 Phytoestrogenic isoflavone compositions |
| 12/20/2001 | WO2001095936A2 Monoterpenes and sesquiterpenes as radiation sensitizers |
| 12/20/2001 | WO2001095901A1 Radioprotective agents |
| 12/20/2001 | WO2001095899A2 Pharmaceutical compositions comprising cannabidiol derivatives |
| 12/20/2001 | WO2001066550A3 Compounds for pdt |
| 12/20/2001 | WO2001062245A3 Bilirubin or biliverdin degradation fragments |
| 12/20/2001 | WO2001062207A3 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 12/20/2001 | WO2001013949A3 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 12/20/2001 | US20010053384 Administering continuous wave ultrasound or pulse-wave ultrasound to a cell bathed in a cocktail containing macromolecules and monitoring the ultrasound using reflected echos of the ultrasound. |
| 12/20/2001 | US20010053355 Treated monocytes incubated to maximize number of functional dendritic cells; then incubated with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents. |
| 12/20/2001 | CA2416796A1 Radioprotective agents |
| 12/19/2001 | EP1164135A1 Substituted metal-phthalocyanines, their preparation and the use thereof |
| 12/19/2001 | EP1163254A2 Trpm-2 antisense therapy |
| 12/19/2001 | EP1163006A1 Method to prevent xenograft transplant rejection |
| 12/19/2001 | EP1163005A1 Model and method for angiogenesis inhibition |
| 12/19/2001 | EP1162988A1 Wafer delivery system |
| 12/19/2001 | EP1162963A1 Means for diagnosing and treating carcinoma |
| 12/19/2001 | EP0683665B1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
| 12/19/2001 | CN1327386A Anti-HIV infection agents and method for treating HIV infection |
| 12/18/2001 | US6332095 Method of exciting photosensitive material |
| 12/18/2001 | US6331286 Methods for high energy phototherapeutics |
| 12/13/2001 | WO2001094349A1 Method and apparatus for inactivation of biological contaminants using photosensitizers |
| 12/13/2001 | US20010051760 Use of photofrin as a radiosensitizer |
| 12/13/2001 | US20010051743 Such as methyl ester; more effective than free form at slowing tumor growth |
| 12/13/2001 | CA2380832A1 Method and apparatus for inactivation of biological contaminants using photosensitizers |
| 12/12/2001 | EP1161433A1 Tyrosine kinase inhibitors |
| 12/12/2001 | EP1161418A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 12/12/2001 | EP0782456B1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 12/12/2001 | CN1326362A Model and method for angiogenesis inhibition |
| 12/11/2001 | US6329401 Enhancement of sleep with a tachykinin antagonist |
| 12/06/2001 | WO2001091794A2 Vitamin d3 analogs as radiosensitizers for the treatment of cancer |
| 12/06/2001 | WO2001035867A3 Ophthalmologic implant |
| 12/06/2001 | WO2001003492A8 Device and method for acting on microorganisms |
| 12/06/2001 | WO2000062808A8 Cobalamin conjugates useful as antitumor agents |
| 12/06/2001 | US20010049350 Adjusting the prolactin and melatonin profiles of the mammal by administering prolactin enhancers or reducers and melatonin so that the prolactin and melatonin profiles conform to or approach normal profiles |
| 12/05/2001 | EP1159387A1 Detergent compositions comprising photobleaching delivery systems |
| 12/05/2001 | EP1159354A1 A composition comprising a photo-oxidising agent and uses of the agent |
| 12/05/2001 | EP1109489A4 Pharmaceutically enhanced low-energy radiosurgery |
| 12/05/2001 | CN1325284A Method for improved imaging and photodynamic therapy |
| 11/29/2001 | WO2001090159A2 Compositions and methods for delivery of a molecule into a cell |
| 11/29/2001 | WO2001089576A2 Preparation hypericin bonded with poly-n-vinylamides |
| 11/29/2001 | WO2001089501A1 Polymerizable compositions and methods of use |
| 11/29/2001 | WO2001003745A3 Therapy and diagnosis of colorectal cancer with radiopharmaceuticals |
| 11/29/2001 | WO2000061162A9 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
| 11/29/2001 | US20010046983 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 11/29/2001 | US20010046450 Irradiation of blood with type c ultraviolet light, deactivating viruses |
| 11/29/2001 | CA2407570A1 Compositions and methods for delivery of a molecule into a cell |
| 11/28/2001 | EP1156827A2 Treatment of neoplastic diseases by radiation |
| 11/28/2001 | EP0783323B1 Transfer of molecules into the cytosol of cells by photosensitizing compounds |
| 11/27/2001 | US6322532 Sonophoresis method and apparatus |
| 11/27/2001 | CA2217573C Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 11/22/2001 | WO2001087348A2 Multifunctional nanodevice platform |
| 11/22/2001 | WO2001087193A1 Electrically conducting nanocomposite materials for biomedical applications |
| 11/22/2001 | WO2001087181A2 Accurate optical treatment of an eye's fundus |
| 11/22/2001 | WO2001008660A3 Targeted fiberless radiative effectors |
| 11/22/2001 | US20010044623 Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
| 11/22/2001 | US20010044583 Gas filled liposomes and their use as ultrasonic contrast agents |
| 11/22/2001 | CA2408172A1 Electrically conducting nanocomposite materials for biomedical applications |
| 11/21/2001 | EP1155694A1 Anti-hiv infection agents and method for treating hiv infection |
| 11/21/2001 | CN1323224A Remedies photochemotherapy |
| 11/15/2001 | WO2001085736A1 Porphyrin-based neutron capture agents for cancer therapy |